Login
From:
Sleep Review
(Uncensored)
subscribe
Takeda’s Narcolepsy Drug Candidate Clears Phase 3 | Sleep Review
https://sleepreviewmag.com/sleep-treatments/pharmaceuticals/emerging-compounds/takeda-narcolepsy-drug-candidate-oveporexton-clears-phase-3/
links
backlinks
Tagged with:
narcolepsy
phase 3
emerging compounds
takeda pharmaceuticals
narcolepsy type 1
Takeda’s investigational orexin-2 receptor agonist oveporexton met all endpoints in two phase 3 trials for narcolepsy type 1.
Roast topics
Find topics
Find it!
